AKT1 and glioblastoma: Regardless of the underlying mechanisms, inhibition of mTORC1 activity by combined treatment may be particularly important given the significant role of the overactivated PTEN/PI3K/AKT/mTORC1 pathway in glioblastoma initiation and progression [65].